The risks for disease progression and death were lower for patients with stage 3b or higher CKD receiving GLP-1 ... RA on kidney function in patients with moderate to advanced CKD, although ...

or it had a different mechanism of action. “There’s a lot of hype and excitement around GLP-1 and like medications,” Youssef. “And the thing I want to see is long-term safety data.

The risks for disease progression and death were lower for patients with stage 3b or higher CKD receiving GLP-1 RA vs DPP4i ... effect of GLP1-RA on kidney function in patients with moderate to ...

Al-Aly noted the mechanisms with kidney stone formation are very different from CKD, and he speculated that the risk for the former could in fact stem from potentially low hydration with GLP-1 RA ...

More clinical trials on the direct and indirect effects of GLP-1s and their mechanisms of action are needed. As the body of research expands on the potential of glucagon-like peptide-1 receptor ...

New research suggests that Ozempic and similar weight loss medications have the potential to be as big a game changer in ...

Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary ...

Weekly treatment with low doses of the GLP-1 receptor agonist semaglutide ... "More research is needed to understand the mechanisms of action of these medications in AUD; nonetheless, the work ...